Archives of Clinical Infectious Diseases

Published by: Kowsar

Plasmid-Mediated Class 1 and 2 Integron Carriage in Drug-Resistant Nosocomial Isolates of Acinetobacter baumannii

Fereshteh Eftekhar 1 , Fatemeh Altayar 1 and Hannan Khidaei 1 , *
Authors Information
1 Departement of Microbiology, Faculty of Biological Sciences and Technology, Shahid Beheshti University, G.C., Tehran, Iran
Article information
  • Archives of Clinical Infectious Diseases: January 2018, 13 (1); e57813
  • Published Online: January 27, 2018
  • Article Type: Research Article
  • Received: December 14, 2016
  • Revised: July 9, 2017
  • Accepted: September 18, 2017
  • DOI: 10.5812/archcid.57813

To Cite: Eftekhar F, Altayar F, Khidaei H. Plasmid-Mediated Class 1 and 2 Integron Carriage in Drug-Resistant Nosocomial Isolates of Acinetobacter baumannii, Arch Clin Infect Dis. 2018 ; 13(1):e57813. doi: 10.5812/archcid.57813.

Copyright © 2018, Archives of Clinical Infectious Diseases. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev. 2008;21(3):538-82. doi: 10.1128/CMR.00058-07. [PubMed: 18625687].
  • 2. Towner KJ. Acinetobacter: an old friend, but a new enemy. J Hosp Infect. 2009;73(4):355-63. doi: 10.1016/j.jhin.2009.03.032. [PubMed: 19700220].
  • 3. Livermore DM, Hope R, Brick G, Lillie M, Reynolds R, Bsac Working Parties on Resistance Surveillance . Non-susceptibility trends among Pseudomonas aeruginosa and other non-fermentative Gram-negative bacteria from bacteraemias in the UK and Ireland, 2001-06. J Antimicrob Chemother. 2008;62 Suppl 2:ii55-63. doi: 10.1093/jac/dkn352. [PubMed: 18819980].
  • 4. Manchanda V, Sanchaita S, Singh N. Multidrug resistant acinetobacter. J Glob Infect Dis. 2010;2(3):291-304. doi: 10.4103/0974-777X.68538. [PubMed: 20927292].
  • 5. Morgan DJ, Weisenberg SA, Augenbraun MH, Calfee DP, Currie BP, Furuya EY, et al. Multidrug-resistant Acinetobacter baumannii in New York City - 10 years into the epidemic. Infect Control Hosp Epidemiol. 2009;30(2):196-7. doi: 10.1086/593207. [PubMed: 19146464].
  • 6. Rowe-Magnus DA, Mazel D. The role of integrons in antibiotic resistance gene capture. Int J Med Microbiol. 2002;292(2):115-25. doi: 10.1078/1438-4221-00197. [PubMed: 12195734].
  • 7. Fluit AC, Schmitz FJ. Class 1 integrons, gene cassettes, mobility, and epidemiology. Eur J Clin Microbiol Infect Dis. 1999;18(11):761-70. doi: 10.1007/s100960050398. [PubMed: 10614949].
  • 8. Nemec A, Dolzani L, Brisse S, van den Broek P, Dijkshoorn L. Diversity of aminoglycoside-resistance genes and their association with class 1 integrons among strains of pan-European Acinetobacter baumannii clones. J Med Microbiol. 2004;53(Pt 12):1233-40. doi: 10.1099/jmm.0.45716-0. [PubMed: 15585503].
  • 9. Zhao WH, Hu ZQ. IMP-type metallo-beta-lactamases in Gram-negative bacilli: distribution, phylogeny, and association with integrons. Crit Rev Microbiol. 2011;37(3):214-26. doi: 10.3109/1040841X.2011.559944. [PubMed: 21707466].
  • 10. Bonnin RA, Nordmann P, Potron A, Lecuyer H, Zahar JR, Poirel L. Carbapenem-hydrolyzing GES-type extended-spectrum beta-lactamase in Acinetobacter baumannii. Antimicrob Agents Chemother. 2011;55(1):349-54. doi: 10.1128/AAC.00773-10. [PubMed: 20956589].
  • 11. Navia MM, Ruiz J, Vila J. Characterization of an integron carrying a new class D beta-lactamase (OXA-37) in Acinetobacter baumannii. Microb Drug Resist. 2002;8(4):261-5. doi: 10.1089/10766290260469516. [PubMed: 12523622].
  • 12. Ramirez MS, Bello H, Gonzalez Rocha G, Marquez C, Centron D. Tn7::In2-8 dispersion in multidrug resistant isolates of Acinetobacter baumannii from Chile. Rev Argent Microbiol. 2010;42(2):138-40. doi: 10.1590/S0325-75412010000200015. [PubMed: 20589338].
  • 13. Constantiniu S, Romaniuc A, Iancu LS, Filimon R, Taraşi, I . Cultural and biochemical characteristics of Acinetobacter spp. strains isolated from hospital units. J Prev Med. 2004;12(3-4):35-42.
  • 14. Woodford N, Ellington MJ, Coelho JM, Turton JF, Ward ME, Brown S, et al. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents. 2006;27(4):351-3. doi: 10.1016/j.ijantimicag.2006.01.004. [PubMed: 16564159].
  • 15. Lee K, Lim JB, Yum JH, Yong D, Chong Y, Kim JM, et al. bla(VIM-2) cassette-containing novel integrons in metallo-beta-lactamase-producing Pseudomonas aeruginosa and Pseudomonas putida isolates disseminated in a Korean hospital. Antimicrob Agents Chemother. 2002;46(4):1053-8. [PubMed: 11897589].
  • 16. Su J, Shi L, Yang L, Xiao Z, Li X, Yamasaki S. Analysis of integrons in clinical isolates of Escherichia coli in China during the last six years. FEMS Microbiol Lett. 2006;254(1):75-80. doi: 10.1111/j.1574-6968.2005.00025.x. [PubMed: 16451182].
  • 17. CLSI . Performance Standards for Antimicrobial Disk Suseptibility Test; Approved Standard. 12th ed. CLSI Document; 2015. p. 29-50.
  • 18. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268-81. doi: 10.1111/j.1469-0691.2011.03570.x. [PubMed: 21793988].
  • 19. Japoni-Nejad A, Sofian M, Belkum A, Ghaznavi-Rad E. Nosocomial outbreak of extensively and pan drug-resistant acinetobacter baumannii in tertiary hospital in central Part of Iran. Jundishapur J Microbiol. 2013;6(8). doi: 10.5812/jjm.9892.
  • 20. Najar Peerayeh S, Karmostaji A. Molecular Identification of Resistance Determinants, Integrons and Genetic Relatedness of Extensively Drug Resistant Acinetobacter baumannii Isolated From Hospitals in Tehran, Iran. Jundishapur J Microbiol. 2015;8(7). doi: 10.5812/jjm.27021v2.
  • 21. Goudarzi H, Douraghi M, Ghalavand Z, Goudarzi M. Assessment of antibiotic resistance pattern in Acinetobacter bumannii carrying bla oxA type genes isolated from hospitalized patients. Novelty Biomed. 2013;1(2):54-61.
  • 22. Fazeli H, Taraghian A, Kamali R, Poursina F, Esfahani BN, Moghim S. Molecular identification and antimicrobial resistance profile of acinetobacter baumannii isolated from nosocomial infections of a teaching hospital in Isfahan, Iran. Avicenna J Clin Microb Infec. 2014;1(2). doi: 10.17795/ajcmi-21489.
  • 23. Goudarzi M, Azimi H. Dissemination of classes 1, 2, and 3 integrons in acinetobacter baumannii strains recovered from intensive care units using polymerase chain reaction-restriction fragment length polymorphism. Jundishapur J Microbiol. 2017;10(5). doi: 10.5812/jjm.13100.
  • 24. Jasemi S, Douraghi M, Adibhesami H, Zeraati H, Rahbar M, Boroumand MA, et al. Trend of extensively drug-resistant Acinetobacter baumannii and the remaining therapeutic options: a multicenter study in Tehran, Iran over a 3-year period. Lett Appl Microbiol. 2016;63(6):466-72. doi: 10.1111/lam.12669. [PubMed: 27626896].
  • 25. Lee YT, Huang LY, Chen TL, Siu LK, Fung CP, Cho WL, et al. Gene cassette arrays, antibiotic susceptibilities, and clinical characteristics of Acinetobacter baumannii bacteremic strains harboring class 1 integrons. J Microbiol Immunol Infect. 2009;42(3):210-9. [PubMed: 19812854].
  • 26. Chen J, Li H, Yang J, Zhan R, Chen A, Yan Y. Prevalence and Characterization of Integrons in Multidrug Resistant Acinetobacter baumannii in Eastern China: A Multiple-Hospital Study. Int J Environ Res Public Health. 2015;12(8):10093-105. doi: 10.3390/ijerph120810093. [PubMed: 26308028].
  • 27. Taherikalani M, Maleki A, Sadeghifard N, Mohammadzadeh D, Soroush S, Asadollahi P, et al. Dissemination of class 1, 2 and 3 integrons among different multidrug resistant isolates of Acinetobacter baumannii in Tehran hospitals, Iran. Pol J Microbiol. 2011;60(2):169-74. [PubMed: 21905636].
  • 28. Koczura R, Przyszlakowska B, Mokracka J, Kaznowski A. Class 1 integrons and antibiotic resistance of clinical Acinetobacter calcoaceticus-baumannii complex in Poznan, Poland. Curr Microbiol. 2014;69(3):258-62. doi: 10.1007/s00284-014-0581-0. [PubMed: 24740302].
  • 29. Huang C, Long Q, Qian K, Fu T, Zhang Z, Liao P, et al. Resistance and integron characterization of Acinetobacter baumannii in a teaching hospital in Chongqing, China. New Microbes New Infect. 2015;8:103-8. doi: 10.1016/j.nmni.2015.09.015. [PubMed: 26649184].
  • 30. Goudarzi H, Azad M, Seyedjavadi SS, Azimi H, Salimi Chirani A, Fallah Omrani V, et al. Characterization of integrons and associated gene cassettes in Acinetobacter baumannii strains isolated from intensive care unit in Tehran, Iran. Journal of Acute Disease. 2016;5(5):386-92. doi: 10.1016/j.joad.2016.08.004.
  • 31. Kamalbeik S, Kouchek M, Baseri Salehi M, Fallah F, Malekan MA, Talaie H. Prevalence of class 2 integrons in multidrug-resistant acinetobacter Baumannii in toxicological ICU patients in Tehran. Iran J Toxicol. 2013;7(22):900-6.
  • 32. Mirnejad R, Mostofi S, Masjedian F. Antibiotic resistance and carriage class 1 and 2 integrons in clinical isolates of Acinetobacter baumannii from Tehran, Iran. Asian Pac J Trop Biomed. 2013;3(2):140-5. doi: 10.1016/S2221-1691(13)60038-6. [PubMed: 23593593].
  • 33. Rastegar-Lari A, Mohammadi-Barzelighi H, Arjomandzadegan M, Nosrati R, Owlia P. Distribution of class I integron among isolates of Acinetobacter baumannii recoverd from burn patients. J Med Bacteriol. 2015;2(1-2):1-11.
  • 34. Ramirez MS, Pineiro S, Argentinian Integron Study G, Centron D. Novel insights about class 2 integrons from experimental and genomic epidemiology. Antimicrob Agents Chemother. 2010;54(2):699-706. doi: 10.1128/AAC.01392-08. [PubMed: 19917745].
  • 35. Koeleman JG, Stoof J, Van Der Bijl MW, Vandenbroucke-Grauls CM, Savelkoul PH. Identification of epidemic strains of Acinetobacter baumannii by integrase gene PCR. J Clin Microbiol. 2001;39(1):8-13. doi: 10.1128/JCM.39.1.8-13.2001. [PubMed: 11136740].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments